×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Amgen CEO gives update on experimental obesity drug
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Yahoo Finance
·
12 hours ago
Amgen obesity drug MariTide: four key questions going forward - STAT
STAT
·
7 hours ago
Amgen expects data from weight-loss drug trial later this year
MarketWatch
·
1 day ago
News about Amgen, Stock
AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
PR Newswire
·
1 day ago
Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet (NASDAQ:AMGN)
Seeking Alpha
·
2 days ago
Why Amgen Stock Zoomed Nearly 12% Higher Today
The Motley Fool
·
4 hours ago
Apple's second-quarter earnings
Stocks to Watch Friday: Apple, Amgen, Exxon, Coinbase
WSJ
·
11 hours ago
Midday movers: Apple, Amgen and Block rise; Cloudflare and Expedia fall
Investing.com
·
10 hours ago
Apple, Amgen rise; Expedia, Fortinet fall, Friday, 5/3/2024
ABC News - Breaking News, Latest News and Videos
·
7 hours ago
Amgen, DraftKings, Live Nation: Trending tickers
Yahoo Finance
Shares of Amgen (AMGN) are soaring at Thursday's market close after reporting first quarter results, with revenue exceeding expectations.
1 day ago
Amgen upgraded, Peloton downgraded: Wall Street's top analyst calls
Yahoo Finance
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that...
13 hours ago
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
Morningstar
Amgen's AMGN first-quarter product sales grew 22%, or 6% excluding the October 2023 acquisition of rare-disease firm Horizon Therapeutics,...
10 hours ago
Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value
markets.businessinsider.com
Amgen Inc (NASDAQ:AMGN) reported first-quarter (Q1) earnings Thursday, touting adjusted EPS of $3.96, which beat the analyst consensus...
11 hours ago
Amgen Pushes Obesity Drug MariTide Forward, Reports 22% Q1 Revenue Growth
BioSpace
Published: May 03, 2024 By Tristan Manalac. Amgen office in FL_iStock, JHVEPhoto. Pictured: Amgen's office in Florida/iStock, JHVEPhoto.
14 hours ago
Analyst recommendations: Alphabet, Amgen, Starbucks, PayPal, Moderna...
MarketScreener
Every morning, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have...
16 hours ago
Amgen scraps experimental weight loss pill, moves forward with injection
CNBC
Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly.
1 day ago